Live Breaking News & Updates on Century therapeutics inc

Stay informed with the latest breaking news from Century therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Century therapeutics inc and stay connected to the pulse of your community

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Netherlands , Malvern , Worcestershire , United-kingdom , United-states , Cambridge , Cambridgeshire , Harvard-university , Massachusetts , Boston , California

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $14.17

Analysts Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $14.17
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Piper-sandler , Adrienne-farid , Nasdaq , Canaccord-genuity-group , Barclays-plc , Wells-fargo-company , Citigroup-inc , Century-therapeutics-inc , Securities-exchange-commission , Century-therapeutics

Medivir AB (publ) (OTCMKTS:MVRBF) versus Century Therapeutics (NASDAQ:IPSC) Head to Head Comparison

Medivir AB (publ) (OTCMKTS:MVRBF – Get Free Report) and Century Therapeutics (NASDAQ:IPSC – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation. Profitability This table compares Medivir AB (publ) […]

Pennsylvania , United-states , Sweden , Huddinge , Stockholm , Philadelphia , Bristol-myers-squibb-company , Century-therapeutics-inc , Get-free-report , Century-therapeutics , Century-therapeutic

Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […]

Adrienne-farid , Century-therapeutics-company-profile , Canaccord-genuity-group , Blackrock-inc , Hermes-inc , Century-therapeutics-inc , Securities-exchange-commission , Nasdaq , Vanguard-group-inc , Century-therapeutics , Get-free-report , Marketbeat-ratings

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]

Adrienne-farid , Century-therapeutics-inc , Nasdaq , Abel-hall , Virtu-financial , Vanguard-group-inc , Century-therapeutics-company-profile , Barclays-plc , Canaccord-genuity-group , Securities-exchange-commission , Century-therapeutics , Get-free-report

Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares

Century Therapeutics Inc (NASDAQ:IPSC), a biotechnology company focused on developing allogeneic cell therapies for cancer and other diseases, has reported an insider sale according to a recent SEC filing.

Century-therapeutics-inc ,

Century Therapeutics, Inc. (NASDAQ:IPSC) Insider Adrienne Farid Sells 22,831 Shares of Stock

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) insider Adrienne Farid sold 22,831 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $5.14, for a total value of $117,351.34. Following the transaction, the insider now owns 114,149 shares in the company, […]

United-states , American , Adrienne-farid , Century-therapeutics-inc , Century-therapeutics-company-profile , Jpmorgan-chase-co , Goldman-sachs-group-inc , Tower-research-capital , Hermes-inc , American-international-group-inc , Nasdaq , Century-therapeutics

Century Therapeutics, Inc. (NASDAQ:IPSC) Insider Sells $117,351.34 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) insider Adrienne Farid sold 22,831 shares of Century Therapeutics stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $5.14, for a total transaction of $117,351.34. Following the sale, the insider now owns 114,149 shares of the company’s stock, valued […]

Ohio , United-states , Adrienne-farid , Wells-fargo-company , Citigroup-inc , Nasdaq , Century-therapeutics-inc , Securities-exchange-commission , Barclays-plc , Century-therapeutics , Get-free-report , Exchange-commission

Avidity Partners Management LP Sells 12,400 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC)

Avidity Partners Management LP lessened its holdings in Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) by 1.1% during the third quarter, HoldingsChannel.com reports. The fund owned 1,098,500 shares of the company’s stock after selling 12,400 shares during the period. Avidity Partners Management LP’s holdings in Century Therapeutics were worth $2,197,000 at the end of the […]

Millennium-management , Nasdaq , Vanguard-group-inc , Renaissance-technologies , Blackrock-inc , Century-therapeutics-inc , Avidity-partners-management , Century-therapeutics , Free-report , Partners-management , State-street-corp

Century Therapeutics (NASDAQ:IPSC) & Athira Pharma (NASDAQ:ATHA) Financial Survey

Century Therapeutics (NASDAQ:IPSC – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Century […]

Philadelphia , Pennsylvania , United-states , Washington , Washington-state-university , Athira-pharma , Athira-pharma-inc , Century-therapeutics-inc , National-institutes-of-health-grant , Biotechnology-inc , Century-therapeutics , Get-free-report